Acne fulminans induced by isotretinoin

Authors

  • Felicitas Rabanal Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina
  • Giselle Aignasse Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina
  • Luciana Soledad Costa Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina
  • Romina Foenquinos Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina
  • Iris Barrio Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/pt9aj877

Keywords:

acne, acne fulminans, isotretinoin, corticosteroids

Abstract

Acne fulminans (AF) is a severe clinical form of inflammatory acne, characterized by an acute and painful outbreak of nodules, papules, hemorrhagic pustules, and ulcers with crusts on the face and upper torso. It may or may not be associated with systemic symptoms and laboratory abnormalities. It typically affects male adolescents with a pre-existing acne.

Author Biographies

  • Felicitas Rabanal, Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina

    Resident Physician, Dermatology Division

  • Giselle Aignasse, Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina

    Resident Physician, Dermatology Division

  • Luciana Soledad Costa, Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina

    Dermatologist, Chief Resident, Dermatology Division

  • Romina Foenquinos, Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina

    Staff Physician, Corrective Dermatology and Autoinflammatory Diseases Sector, Dermatology Division

  • Iris Barrio, Dr. José María Ramos Mejía General Hospital, Buenos Aires, Argentina

    Staff Physician, in charge of the Sexually Transmitted Infections, Genital Pathology and Autoinflammatory Diseases Sector, Dermatology Division

References

I. Gutiérrez-Meré R, Tajes I, Diéguez P, Soto-García D, et al. Acne fulminans: a narrative review. Actas Dermosifiliogr. 2023;114:763-771.

II. Dall'oglio F, Puglisi DF, Nasca MR, Micali G. Acne fulminans. G Ital Dermatol Venereol. 2020;155:711-718.

III. Greywal T, Zaenglein AL, Baldwin HE, Bhatia N, et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol. 2017;77:109-117.

IV. Trave I, Donadoni R, Cozzani E, D'Agostino F, et al. Acne fulminans and its multiple associated factors: a systematic review. Eur J Dermatol. 2023;33:624-634.

V. Saleh HM, Zito PM. Acne fulminans. [Internet]. Treasure Island (FL): StatPearls; 2025. Disponible en: www.ncbi.nlm.nih.gov/books/NBK459326.

VI. Woźna J, Korecka K, Stępka J, Bałoniak A, et al. Acne fulminans treatment: case report and literature review. Front Med. 2024;11.

VII. Gier H, Israeli A, Cusick A, Merritt D. Use of interleukin-12/23 inhibitor for the management of acne fulminans. Cureus. 2023;15.

VIII. Sánchez-Velázquez A, Falkenhain-López D, Arroyo-Andrés J, Montero-Menárguez J, et al. Apremilast: a novel adjuvant treatment for refractory isotretinoin-induced acne fulminans. Dermatol Ther. 2022;35.

IX. Lahrougui A, Aboudourib M, Bendaoud L, Amal S, et al. The efficiency of systemic dapsone in the treatment of acne fulminans: a clinical case report. Cureus. 2025;17:e83234.

X. Legal K, Misery L. Isotretinoin-induced acne fulminans without systemic symptoms treated successfully with oral dapsone. Acta Derm Venereol. 2020;100:1-2.

XI. Quan NG, Chrabieh R, Sadeghpour M, Kohn LL. A practice approach to acne fulminans in adolescents. Am J Clin Dermatol. 2024;25:967-974.

XII. Lee HE, Chang IK, Lee Y, Kim CD, et al. Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study. J Eur Acad Dermatol Venereol. 2014;28:1654-1660.

XIII. Dumont S, Lorthe E, Loizeau A, Richard V, et al. Acne-related quality of life and mental health among adolescents: a cross-sectional analysis. Clin Exp Dermatol. 2025;50:795-803.

Downloads

Published

2026-04-28

Issue

Vol. 32 No. 1 (2026): January-april

Section

Original Articles

License

Copyright (c) 2026 On behalf of the authors. Reproduction rights: Argentine Dermatology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.

 

Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor